Points to consider

Success in the critical illness (CI) market is likely to be measured by two overriding criteria - marketability and risk management. There needs to be a product which people will buy, but there also needs to be reasonable protection for the providers of the life offices' and reinsurers' capital by not exposing them to unnecessary risks. Either of these criteria on its own makes for an unsuccessful product; achieving the right balance is crucial. In a series of two articles, we examine some possible product designs that aim to tackle these challenges. This article looks at the disability un...